Atrial Natriuretic Peptide (ANP), rat: Mechanism, Evidence, and Research Integration

Executive Summary: Atrial Natriuretic Peptide (ANP), rat, is a 28-amino acid peptide hormone critical for blood pressure homeostasis and fluid balance (APExBIO, product page). It is secreted by atrial myocytes in response to atrial stretch and neurohumoral stimuli. ANP acts as a potent vasodilator and promotes natriuresis, thus reducing circulating blood volume and pressure. The high-purity ANP peptide from APExBIO (≥95.9% by HPLC/MS) is validated for cardiovascular and renal research, ensuring consistent performance in experimental systems (Zhang et al., 2022). ANP also intersects with adipose tissue metabolism, extending its utility beyond classical cardiovascular endpoints.

Biological Rationale

Atrial Natriuretic Peptide (ANP) is synthesized, stored, and released by atrial myocytes in the mammalian heart in response to atrial distension, angiotensin II, endothelin, and sympathetic activation (APExBIO). Its primary physiological roles include regulating blood pressure, promoting natriuresis (sodium excretion), and modulating adipose tissue metabolism. ANP counteracts the effects of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, maintaining circulatory homeostasis at both acute and chronic timepoints (see Atrial Natriuretic Peptide: Advanced Workflows in Cardiov...—this article expands on peptide sequence-specific benchmarks for reproducibility). ANP receptors are widely expressed in cardiovascular, renal, and adipose tissues, enabling system-wide effects.

Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

ANP exerts its actions primarily by binding to natriuretic peptide receptor-A (NPR-A), a guanylyl cyclase-coupled receptor. This interaction increases intracellular cyclic guanosine monophosphate (cGMP) levels, leading to smooth muscle relaxation (vasodilation) and enhanced renal sodium excretion (APExBIO). The core peptide sequence, H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, is essential for receptor activation. ANP also inhibits renin and aldosterone secretion, further reducing sodium retention. In adipose tissue, ANP stimulates lipolysis via cGMP-dependent protein kinase pathways (Zhang et al., 2022). These mechanisms collectively decrease blood volume and pressure while modulating metabolic homeostasis.

Evidence & Benchmarks

• ANP induces potent vasodilation in rat aortic rings at concentrations as low as 10 nM, measurable via cGMP elevation and smooth muscle relaxation (Zhang et al., 2022).
• ANP administered to rats increases urinary sodium excretion (natriuresis) within 30–60 minutes post-injection, with maximal effects observed at 50–100 μg/kg (APExBIO).
• Purity ≥95.92% is confirmed by HPLC and mass spectrometry for the APExBIO product, ensuring reproducibility in cardiovascular and renal physiology assays (product certificate).
• ANP's modulation of adipose tissue metabolism is supported by studies showing increased lipolysis via cGMP-dependent pathways in rat adipocytes (Zhang et al., 2022).
• ANP is soluble at ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water but is insoluble in ethanol, which is critical for experimental setup (APExBIO).

Applications, Limits & Misconceptions

Rat Atrial Natriuretic Peptide (ANP) is widely used to model blood pressure regulation, renal sodium handling, and metabolic responses in cardiovascular and renal physiology research. Researchers employ ANP in cell viability, proliferation, and cytotoxicity assays, leveraging its reproducible effects and validated purity (Scenario-Driven Laboratory Solutions with Atrial Natriure...—this article focuses on scenario-based troubleshooting, while the current review details molecular benchmarks and mechanistic pathways).

ANP's role extends to neurocardiometabolic research, where it is used to study crosstalk between cardiovascular, renal, and neuroimmune systems (Atrial Natriuretic Peptide (ANP), Rat: Unraveling Neuroca...). Unlike some prior reviews, this article provides updated, product-specific evidence relevant to bench reproducibility.

Common Pitfalls or Misconceptions

• ANP is not effective when dissolved in ethanol due to its insolubility; use DMSO or water as solvents (APExBIO).
• Long-term storage of ANP solutions is not recommended; prepare fresh aliquots for each experiment (APExBIO).
• ANP's effects are species-specific; findings in rat models may not fully translate to human physiology (Zhang et al., 2022).
• High doses may cause hypotension and off-target effects; titrate dosing carefully based on study design.
• ANP should not be used as a direct substitute for other natriuretic peptides (e.g., BNP) without validation of functional equivalence.

Workflow Integration & Parameters

The APExBIO Atrial Natriuretic Peptide (ANP), rat (SKU A1009) is supplied as a solid and should be stored at -20°C. For experimental use, dissolve at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water. Avoid ethanol as a solvent. Prepare fresh solutions before each use to preserve activity. The product's purity (≥95.92%) is confirmed by HPLC and MS, supporting quantitative and qualitative research applications. Utilize within standard cardiovascular, renal, or metabolic assay protocols. For advanced workflows and troubleshooting, see Atrial Natriuretic Peptide: Optimizing Rat Cardiovascular...—this prior article summarizes workflow steps, while the present article adds solubility and storage best practices.

Conclusion & Outlook

Atrial Natriuretic Peptide (ANP), rat, from APExBIO is a validated tool for mechanistic and translational research in blood pressure regulation, natriuresis, and adipose tissue metabolism. Its high purity and standardized characterization enable reproducible results across cardiovascular, renal, and metabolic physiology. Ongoing studies continue to expand its applications, including potential roles in neuroimmune modulation and metabolic disease. For detailed product specifications and ordering, visit the Atrial Natriuretic Peptide (ANP), rat product page.